Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
178
NCT00959153
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney
Phase: Phase 3
Role: Lead Sponsor
Start: Jun 30, 2010
Completion: Aug 31, 2011
NCT06088121
Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
Phase: N/A
Start: May 15, 2023
Completion: Jun 30, 2027